Cochrane · systematic review · CD012789
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger
Leow, MQ, Zheng, Q, Shi, L, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
MusculoskeletalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 28.6%Low 5 · 71.4%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
NSAID injection compared to glucocorticoid injection for trigger finger
Population: adults (> 18 years of age) with trigger finger
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Resolution at 12 to 24 weeks Quinell Grade (range 0 to 4, resolved disease is grade 0) NSAID injection vs glucocorticoid injection | RR 0.83 [0.62, 1.11] | 2 studies · 231 participants | Low Downgraded: risk of bias |
Persistent moderate to severe symptoms at 12 to 24 weeks NSAID injection vs glucocorticoid injection | RR 2.03 [1.19, 3.46] | 2 studies · 231 participants | Low Downgraded: risk of bias |
Recurrence at 12 to 24 weeks NSAID injection vs glucocorticoid injection | RR 0.07 [0.01, 0.38] | 2 studies · 231 participants | Very low Downgraded: risk of bias, imprecision |
Total active motion NSAID injection vs glucocorticoid injection | no estimate extracted | 1 study · 99 participants | Low Downgraded: risk of bias |
Residual pain NSAID injection vs glucocorticoid injection | RR 0.84 [0.54, 1.31] | 2 studies · 231 participants | Low Downgraded: risk of bias |
Participant‐reported treatment success NSAID injection vs glucocorticoid injection | RR 0.95 [0.74, 1.23] | 1 study · 121 participants | Low Downgraded: risk of bias |
Adverse events NSAID injection vs glucocorticoid injection | RR 2 | 2 studies · 231 participants | Very low Downgraded: risk of bias |